Toxoplasmosis in pregnancy and its transmission to the fetus.
作者信息
Desmonts G, Couvreur J
出版信息
Bull N Y Acad Med. 1974 Feb;50(2):146-59.
Abstract
摘要
相似文献
1
Toxoplasmosis in pregnancy and its transmission to the fetus.孕期弓形虫病及其向胎儿的传播。
Bull N Y Acad Med. 1974 Feb;50(2):146-59.
2
Congenital toxoplasmosis. A prospective study of 378 pregnancies.先天性弓形虫病。对378例妊娠的前瞻性研究。
N Engl J Med. 1974 May 16;290(20):1110-6. doi: 10.1056/NEJM197405162902003.
3
Toxoplasmosis.
Med J Aust. 1970 Aug 29;2(9):418-21.
4
5
New perspectives in the chemoprophylaxis of toxoplasmosis.弓形虫病化学预防的新视角。
J Chemother. 1989 Feb;1(1):46-51. doi: 10.1080/1120009x.1989.11738863.
6
[Treatment of toxoplasmosis acquired during pregnancy with spiramycin].
Zentralbl Gynakol. 1983;105(17):1104-7.
7
Toxoplasmosis.弓形虫病
J Natl Med Assoc. 1973 Sep;65(5):399-401 passim.
8
[Epidemiology, clinical aspects and therapy of toxoplasmosis].[弓形虫病的流行病学、临床特征及治疗]
Med Klin. 1970 Feb 13;65(7):283-8.
9
[Congenital toxoplasmosis. Evaluation of the benefit of prenatal therapy].[先天性弓形虫病。产前治疗益处的评估]
J Gynecol Obstet Biol Reprod (Paris). 1976 Mar;5(2):265-9.
10
[Epidemiology of toxoplasmosis].[弓形虫病的流行病学]
Rev Med Suisse Romande. 1974 Apr;94(4):261-9.
引用本文的文献
1
A review of natural products as a source of next-generation drugs against apicomplexan parasites.天然产物作为抗顶复门寄生虫的下一代药物来源的综述。
NPJ Antimicrob Resist. 2025 Jun 6;3(1):51. doi: 10.1038/s44259-025-00119-x.
2
Preexisting vaccine-primed heterosubtypic T cell immunity protects the maternal-fetal unit from adverse influenza outcomes in mice.预先存在的疫苗引发的异源亚型T细胞免疫可保护母胎单位免受小鼠流感不良后果的影响。
J Clin Invest. 2025 Jan 2;135(1):e179230. doi: 10.1172/JCI179230.
3
Modeling the human placental barrier to understand ´s vertical transmission.建立人类胎盘屏障模型以了解垂直传播。
Front Cell Infect Microbiol. 2023 Mar 9;13:1130901. doi: 10.3389/fcimb.2023.1130901. eCollection 2023.
4
Anti- IgM Long Persistence: What Are the Underlying Mechanisms?抗IgM的长期持续存在：潜在机制是什么？
Microorganisms. 2022 Aug 17;10(8):1659. doi: 10.3390/microorganisms10081659.
5
Evaluation of Essential Oil and Its Active Ingredients as Potential Drugs for the Treatment of Toxoplasmosis.评价精油及其活性成分作为治疗弓形虫病的潜在药物。
Front Cell Infect Microbiol. 2021 Nov 22;11:793089. doi: 10.3389/fcimb.2021.793089. eCollection 2021.
6
Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections.先天性弓形虫病在人类中的情况：全球先天性感染率的最新更新。
Parasitology. 2021 Oct;148(12):1406-1416. doi: 10.1017/S0031182021001013. Epub 2021 Jun 18.
7
Anti-parasitic Activity of Essential Oil Against .香精油对……的抗寄生虫活性
Front Cell Dev Biol. 2021 Feb 18;9:616340. doi: 10.3389/fcell.2021.616340. eCollection 2021.
8
Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings.先天性弓形虫病的预防与缓解。不同环境下的经济成本与效益。
Food Waterborne Parasitol. 2019 Jun 1;16:e00058. doi: 10.1016/j.fawpar.2019.e00058. eCollection 2019 Sep.
9
Treatment of toxoplasmosis: Current options and future perspectives.弓形虫病的治疗：当前选择与未来展望
Food Waterborne Parasitol. 2019 Apr 1;15:e00036. doi: 10.1016/j.fawpar.2019.e00036. eCollection 2019 Jun.
10
Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.弓形虫病的治疗：历史视角、动物模型和当前临床实践。
Clin Microbiol Rev. 2018 Sep 12;31(4). doi: 10.1128/CMR.00057-17. Print 2018 Oct.
本文引用的文献
1
[Spiramycin therapy of experimental toxoplasmosis in mice].[小鼠实验性弓形虫病的螺旋霉素治疗]
Presse Med (1893). 1958 May 28;66(42):957-8.
2
[Theoretical bases of the prevention by spiramycin of congenital toxoplasmosis in pregnant women].[螺旋霉素预防孕妇先天性弓形虫病的理论基础]
Presse Med (1893). 1968 Dec 7;76(48):2266.
3
[Cultivation tests of toxoplasma gondii from placentas and abortion material and serological examination of women with toxoplasma antibodies].[胎盘及流产材料中弓形虫的培养试验以及弓形虫抗体阳性女性的血清学检查]
Z Geburtshilfe Perinatol. 1972 Aug;176(4):324-30.
4
Clinical Toxoplasmosis--50 years.
Trans R Soc Trop Med Hyg. 1972;66(4):549-71. doi: 10.1016/0035-9203(72)90300-8.
5
Toxoplasmosis in pregnancy.妊娠期弓形虫病
J Obstet Gynaecol Br Commonw. 1972 Dec;79(12):1115-8. doi: 10.1111/j.1471-0528.1972.tb11897.x.
Zotero 插件